NovoCure
NVCR
NVCR
315 hedge funds and large institutions have $5.64B invested in NovoCure in 2022 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 90 increasing their positions, 107 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
16% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 107
17% less capital invested
Capital invested by funds: $6.79B → $5.64B (-$1.16B)
18% less call options, than puts
Call options by funds: $69.3M | Put options by funds: $84.2M
Holders
315
Holding in Top 10
4
Calls
$69.3M
Puts
$84.2M
Top Buyers
| 1 | +$126M | |
| 2 | +$41.7M | |
| 3 | +$23.7M | |
| 4 |
Morgan Stanley
New York
|
+$20.8M |
| 5 |
Jane Street
New York
|
+$17.9M |
Top Sellers
| 1 | -$238M | |
| 2 | -$64.5M | |
| 3 | -$19.7M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$15.6M |
| 5 |
State Street
Boston,
Massachusetts
|
-$14.6M |